What Is Anika Therapeutics Inc. (ANIK) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on Anika Therapeutics Inc. at its current price of $15.77. The composite intrinsic value is estimated at $13.10 (-16.9% average return), with 7 models flagging overvaluation risk. The most optimistic model, FTNN, places fair value at $38.77 (+145.8%), while ML-RIV — the most conservative — estimates $1.34 (-91.5%). This +237.4% gap reflects genuine analytical uncertainty about Anika Therapeutics Inc.'s intrinsic worth.
What Do the Models Say About ANIK?
11 of 13 models are currently active for ANIK. Of these, 3 models suggest upside while 8 models suggest overvaluation. The Bayesian DCF estimates ANIK's intrinsic value at $7.26, implying -53.9% downside from the current price. See which stocks rank higher →
How Does ANIK Rank in Drug Manufacturers - Specialty & Generic?
Among 13 Drug Manufacturers - Specialty & Generic stocks, ANIK ranks #6 by Quality of Company score. CirclFi's QOC score of 6.6/10 evaluates 32 fundamental signals. A score of 6.6 indicates above-average quality.
As a pharmaceutical industry, Anika Therapeutics Inc. operates in a sector where clinical trial success rate is a critical driver of valuation. Investors evaluating ANIK should weigh these sector-specific dynamics alongside our model-derived fair values.
Is ANIK a Value Trap?
CirclFi's Value Trap algorithm assigns ANIK a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
11 of 13 models are active for Anika Therapeutics Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Anika Therapeutics Inc.'s fundamental quality profile registers 6.6/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +237.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every ANIK valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across ANIK's 11 active models, average confidence is 35%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad